Patients gain structure, guidance, and flexibility that adapts as their needs evolve
If that happens, well update this guide accordingly and continue pointing you to the best pathways to prescription access
Recently, the FDA approved a label expansion for Zepbound to include a four-dose single-patient use KwikPen, making the monthly administration process even more convenient for patients
Ive had patients tell me that after starting GLP-1 therapy, they no longer experience cravings for alcoholsomething neither they nor I expected. GLP-1s for Weight Loss: A Long-Term Commitment While GLP-1s have been beneficial for many, they are not a one-size-fits-all solution
The study aims to compare the cardioprotective effects of tirzepatide with another FDA-approved GLP-1 agonist called dulaglutide and is expected to be concluded by late 2024 [29]
With any oral medication, it may take one to six hours before youll start to feel the effects